DE-130A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DE-130A, covering 2024-05-28 to 2024-05-28. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]